Drug Delivery Iontophoresis Electrode

Drug Delivery Iontophoresis Electrode
Details:
Materials: Constructed with a medical-grade PET carrier and a screen-printed Ag/AgCl conductive layer. The drug reservoir consists of a highly absorbent cellulose or non-woven matrix that prevents fluid leakage.

ISO Standards: Manufactured in ISO 13485 certified facilities. Biocompatibility data complies with ISO 10993 (Sensitization, Irritation, and Cytotoxicity).

Conductivity/Adhesion: The Ag/AgCl layer is engineered to maintain a stable electrode potential during constant DC output. The adhesive border utilizes a high-tack acrylic to ensure the drug reservoir remains in full contact with the skin, preventing "dry spots" that cause burns.

MOQ:20,000+ for customized package.
Send Inquiry
Download
Description
Technical Parameters
 

Iontophoresis Electrodes | Ag/AgCl Drug Delivery Patches | TOP-RANK

 

 

Technical-grade iontophoresis electrodes for active transdermal drug delivery. Features Silver/Silver Chloride (Ag/AgCl) technology to ensure pH stability and controlled ion migration.

 

Product Overview

 

These are active transdermal delivery interfaces designed to facilitate the migration of ionized drug molecules across the skin barrier using low-intensity direct current (DC). Unlike passive patches, these electrodes utilize electrical repulsion to deliver localized medication. We supply these to B2B clinical providers for the treatment of inflammatory conditions and localized pain.

 

Key Features

 

  • Ag/AgCl Polarization Control

    Standard carbon electrodes used with DC current cause rapid electrolysis of water, leading to extreme pH shifts at the skin interface. Our electrodes utilize a stabilized Silver/Silver Chloride (Ag/AgCl) coating. This chemistry acts as a reversible electrode, maintaining a neutral pH and preventing the chemical burns associated with non-buffered iontophoresis interfaces.

     

  • Hydrophobic Adhesive Barrier

    Fluid migration into the adhesive border can lead to localized "shorts" and uneven drug delivery. We use a hydrophobic foam or PE carrier as a perimeter seal. This ensures the medication remains confined within the absorbent reservoir, maintaining the calculated drug concentration and current density throughout the procedure.

     

  • Calibrated Reservoir MVTR

    The rate of ion migration is affected by the Moisture Vapor Transmission Rate (MVTR) of the backing material. We utilize a low-MVTR PET backing to prevent premature evaporation of the medication during therapy. This maintains the ionic strength of the solution, allowing for linear drug delivery over the entire treatment cycle.

 

Applications

 

Physical Therapy

Localized administration of dexamethasone or lidocaine for tendonitis, bursitis, and plantar fasciitis.

 

Sports Medicine

Accelerated recovery of acute inflammatory injuries.

 

Dermatology

Active delivery of aesthetic or therapeutic agents through the stratum corneum.

 

OEM & Private Label

 

We operate specialized manufacturing hubs in China and Vietnam to support global B2B supply chains and mitigate Section 301 tariffs.

  • Custom Sizes: Tooling available for "Runway Round," Rectangular, or Square reservoir geometries.
  • Packaging: Individual sterile-barrier foil pouches or bulk non-sterile clinical packs.
  • Logistics: Private label branding on pouches and master cartons with integrated QC batch tracking.

 

Certifications

 

Regulatory: FDA 510(k), CE (MDR), and UKCA documentation ready for verification.

Systems: ISO 13485 and MDSAP audited.

QC Protocols: Every batch is tested for reservoir absorption capacity, Ag/AgCl coating continuity, and adhesive peel strength.

 

FAQ

Q: Why is Ag/AgCl mandatory for drug delivery but not for TENS?

A: TENS uses AC (alternating current), which does not cause significant ion accumulation. Iontophoresis uses DC (direct current). Without Ag/AgCl, the DC current will create acidic or alkaline environments on the skin, causing severe chemical burns within minutes.

Q: Can the reservoir be pre-filled?

A: Most B2B clinical versions are supplied dry to allow the clinician to add the specific prescribed medication. However, we offer OEM development for pre-filled stable aqueous solutions under specific regulatory filings.

CTA

 

B2B project managers can request technical drawings and Ag/AgCl stability test data for qualification.

👉 [Request Samples for Drug Migration Testing]

 

 

 

Hot Tags: drug delivery iontophoresis electrode, China drug delivery iontophoresis electrode manufacturers, suppliers, factory, dexamethasone for iontophoresis patch, Iontophoresis Pad, Iontophoresis Patches, iontophoresis cortisone patch, iomed patch, ionto pads

Specifications

 

Serial Number

Product Model

Product Appearance

Fill Volume

Maximum current

/maximum dose

Electrode types

01

ION-T01

Iontophoresis Pad factory

1.5 cc

4.0 mA / 80mA-min

Active drug delivery electrode

02

ION-T02

Iontophoresis electrode supplier

2.5 cc

4.0 mA / 80mA-min

Active drug delivery electrode

03

ION-T03

iontophoresis electrode

4.0 cc

4.0 mA / 80mA-min

Active drug delivery electrode

04

ION-T04

Iontophoresis patches supplier

2.0 cc

4.0 mA / 80mA-min

Active drug delivery electrode

05

ION-T05

image005

/

/

Return electrode

Send Inquiry